US Bancorp
SMMT icon

US Bancorp’s Summit Therapeutics SMMT Stock Holding History

US Bancorp’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35.1K Buy
1,850
+1,525
+469% +$24.7K ﹤0.01% 2858
2025
Q4 		$5.68K Sell
325
-356
-52% -$6.7K ﹤0.01% 3488
2025
Q3 		$14.1K Buy
681
+333
+96% +$8.07K ﹤0.01% 3207
2025
Q2 		$7.41K Buy
348
+220
+172% +$5.02K ﹤0.01% 3522
2025
Q1 		$2.47K Sell
128
-35
-21% -$702 ﹤0.01% 3831
2024
Q4 		$2.91K Buy
+163
New +$3.16K ﹤0.01% 3777
2021
Q4 		– Sell
-339
Closed -$2K – 4216
2021
Q3 		$2K Sell
339
-887
-72% -$6.37K ﹤0.01% 3917
2021
Q2 		$9K Sell
1,226
-572
-32% -$3.75K ﹤0.01% 3453
2021
Q1 		$10K Buy
1,798
+1,582
+732% +$10.2K ﹤0.01% 3296
2020
Q4 		$1K Buy
+216
New +$915 ﹤0.01% 3703

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return